<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

true
true

CLAIM ID

f52c869f

Low levels of vitamin D are associated with an increased risk of COVID-19 infection.

Low-level vitamin D in blood plasma may raise the risk of contracting COVID-19. It appears to be associated with the possibility of hospitalization.

The researchers from the Leumit Health Services(LHS) and the Azrieli Faculty of Medicine of Bar-Ilan University studied the lower level of Vitamin D in positive COVID-19 patients. They examined around 7,807 individuals, of which 782(10.1%) were COVID-19 positive, and 7,025(89.9%) were negative. Individuals who testest positive showed a significantly lower plasma vitamin D compared to negative for COVID-19. In the immune system, vitamin D plays an essential role. Vitamin D is known to enhance immune cells' function, including T-cells and macrophages, that protect the body against pathogens. Low vitamin D level was related to the risk of hospitalization due to COVID-19 infection, said Dr. Eugene Merzon, Head of the Department of Managed Care, and a leading researcher of the LHS group. Low vitamin D status is also associated with other non-communicable diseases and increases susceptibility to infectious disease, mostly upper respiratory tract infections. The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

misleading

397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.